COMBINED PRESENCE OF THREE MGMT GENE-POLYMORPHISMS IN A GLIOBLASTOMA PATIENT, WHO DEVELOPED SEVERE MYELOSUPPRESSION FOLLOWING TEMOZOLOMIDE CHEMOTHERAPY

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAltinoz, M. A.
dc.contributor.authorOzek, E.
dc.contributor.authorEkmekci, C. G.
dc.contributor.authorYenmis, G.
dc.contributor.authorElmaci, I.
dc.date.accessioned2025-10-16T15:28:28Z
dc.date.issued2016
dc.description.abstract12th Meeting of the European-Association-of-Neuro-Oncology, GERMANY, OCT 12-16, 2016
dc.identifier.otherWOS:000386200200140
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8662
dc.publisherOXFORD UNIV PRESS INC
dc.sourceNEURO-ONCOLOGY
dc.titleCOMBINED PRESENCE OF THREE MGMT GENE-POLYMORPHISMS IN A GLIOBLASTOMA PATIENT, WHO DEVELOPED SEVERE MYELOSUPPRESSION FOLLOWING TEMOZOLOMIDE CHEMOTHERAPY
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS